| Drug Name |
Optimark |
| Drug ID |
BADD_D01621 |
| Description |
Gadoversetamide, marketed under the trade name OptiMARK, is a gadolinium compound used as a contrast agent in magnetic resonance imaging (MRI), particularly imaging of the brain, spine and liver. |
| Indications and Usage |
Gadoversetamide is an MRI contrast agent used for MRI diagnostic procedures to provide increased enhancement and visualization of lesions of the brain, spine and liver, including tumors. |
| Marketing Status |
approved; investigational |
| ATC Code |
V08CA06 |
| DrugBank ID |
DB00538
|
| KEGG ID |
D01646
|
| MeSH ID |
C112666
|
| PubChem ID |
6435809
|
| TTD Drug ID |
D0X0GI
|
| NDC Product Code |
Not Available |
| UNII |
Not Available
|
| Synonyms |
gadoversetamide | OptiMARK |
